Silodyx/Urorec silodosin regulatory update

EMEA's CHMP issued a positive opinion on an MAA from Recordati for Silodyx/Urorec silodosin to treat signs and symptoms of benign prostatic hyperplasia (BPH). Recordati has rights to the selective ad...